ASCI
You are here: Skip Navigation LinksHome > HCP > ASCI > Melanoma

ASCI in melanoma

This section is devoted to the cancer immunotherapy with MAGE-A3 ASCI trials conducted by GSK:

  • Phase II trial in completely resected, stage IB or II NSCLC patients.
  • A pivotal Phase III trial, the MAGRIT trial, is now ongoing in NSCLC patients.

New user?

Welcome to www.gsk-asci.com

If this is your first time at this site, please click here to register.

Register now

Why register?

For legal reasons, this page is intended solely for healthcare professionals. This is why we ask you to register.

Last update: 27-May-2009
ASCIs are investigational compounds